resveratrol has been researched along with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 4 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alvira, D; Camins, A; Canudas, AM; Folch, J; Pallàs, M; Verdaguer, E; Yeste-Velasco, M | 1 |
| Chen, BY; Chiou, RY; Hsieh, CW; Huang, JC; Ko, MC; Lee, MC; Lu, KT; Peng, CH; Wung, BS; Yang, YL | 1 |
| Bonfanti Santos, D; Colle, D; da Rocha Lindner, G; Daniel Prediger, R; Farina, M; Gasnhar Moreira, EL; Khalil, NM; Mara Mainardes, R | 1 |
| Duan, YL; Li, GF; Wang, ZH; Zhang, JL; Zhang, QS; Zheng, DL | 1 |
| Cui, XX; Dong, SY; Feng, Y; Guo, YJ; Kuo, SH; Liu, T; Tan, EK; Wu, YC; Yin, M; Zhao, WJ | 1 |
| Abolaji, AO; Adedara, AO; Adie, MA; Farombi, EO; Vicente-Crespo, M | 1 |
6 other study(ies) available for resveratrol and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine
| Article | Year |
|---|---|
Comparative analysis of the effects of resveratrol in two apoptotic models: inhibition of complex I and potassium deprivation in cerebellar neurons.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Animals, Newborn; Antioxidants; Apoptosis; Cells, Cultured; Cerebellum; Dose-Response Relationship, Drug; Drug Interactions; Electron Transport Complex I; Gene Expression Regulation; Neurons; Potassium; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Resveratrol; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Sirtuin 1; Sirtuins; Stilbenes; Time Factors | 2007 |
Neuroprotective effects of resveratrol on MPTP-induced neuron loss mediated by free radical scavenging.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Ataxia; Corpus Striatum; Free Radical Scavengers; Hand Strength; Male; Mice; Mice, Inbred BALB C; Motor Activity; Neurons; Neuroprotective Agents; Parkinson Disease, Secondary; Resveratrol; Stilbenes | 2008 |
Improved neuroprotective effects of resveratrol-loaded polysorbate 80-coated poly(lactide) nanoparticles in MPTP-induced Parkinsonism.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Antioxidants; Corpus Striatum; Dopaminergic Neurons; Drug Carriers; Male; Memory; Mice; Mice, Inbred C57BL; Neuroprotective Agents; Olfactory Perception; Oxidative Stress; Parkinson Disease, Secondary; Polyesters; Polysorbates; Resveratrol; Stilbenes | 2015 |
MicroRNA-214 participates in the neuroprotective effect of Resveratrol via inhibiting α-synuclein expression in MPTP-induced Parkinson's disease mouse.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; alpha-Synuclein; Animals; Cell Line, Tumor; Down-Regulation; Gene Expression Regulation; Humans; Male; Mice; Mice, Inbred C57BL; MicroRNAs; Neuroblastoma; Neuroprotective Agents; Parkinsonian Disorders; Resveratrol; RNA, Messenger; Stilbenes; Up-Regulation | 2015 |
Resveratrol alleviates MPTP-induced motor impairments and pathological changes by autophagic degradation of α-synuclein via SIRT1-deacetylated LC3.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Acetylation; alpha-Synuclein; Animals; Autophagy; Behavior, Animal; Corpus Striatum; Disease Models, Animal; Dopamine; Male; Mice, Inbred C57BL; Microtubule-Associated Proteins; Neuroprotective Agents; Parkinson Disease, Secondary; Resveratrol; Sirtuin 1; Stilbenes | 2016 |
Resveratrol prolongs lifespan and improves 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced oxidative damage and behavioural deficits in Drosophila melanogaster.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Acetylcholinesterase; Animals; Antioxidants; Behavior, Animal; Catalase; Cell Survival; Drosophila melanogaster; Glutathione Transferase; Hydrogen Peroxide; Longevity; Nitric Oxide; Oxidative Stress; Parkinson Disease, Secondary; Resveratrol | 2018 |